PL3737378T3 - Krople do oczu z palonosetronem do leczenia nudności i wymiotów lub zapobiegania im - Google Patents

Krople do oczu z palonosetronem do leczenia nudności i wymiotów lub zapobiegania im

Info

Publication number
PL3737378T3
PL3737378T3 PL19702482.1T PL19702482T PL3737378T3 PL 3737378 T3 PL3737378 T3 PL 3737378T3 PL 19702482 T PL19702482 T PL 19702482T PL 3737378 T3 PL3737378 T3 PL 3737378T3
Authority
PL
Poland
Prior art keywords
palonosetron
nausea
vomiting
prevention
treatment
Prior art date
Application number
PL19702482.1T
Other languages
English (en)
Inventor
Jouko Levijoki
Sari PAPPINEN
Lasse SALORANTA
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of PL3737378T3 publication Critical patent/PL3737378T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL19702482.1T 2018-01-12 2019-01-11 Krople do oczu z palonosetronem do leczenia nudności i wymiotów lub zapobiegania im PL3737378T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20185035 2018-01-12
PCT/FI2019/050017 WO2019138162A1 (en) 2018-01-12 2019-01-11 Palonosetron for the treatment or prevention of nausea and vomiting

Publications (1)

Publication Number Publication Date
PL3737378T3 true PL3737378T3 (pl) 2023-07-31

Family

ID=65243604

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19702482.1T PL3737378T3 (pl) 2018-01-12 2019-01-11 Krople do oczu z palonosetronem do leczenia nudności i wymiotów lub zapobiegania im

Country Status (11)

Country Link
US (1) US11433021B2 (pl)
EP (1) EP3737378B1 (pl)
DK (1) DK3737378T3 (pl)
ES (1) ES2943933T3 (pl)
FI (1) FI3737378T3 (pl)
HR (1) HRP20230471T1 (pl)
HU (1) HUE062180T2 (pl)
PL (1) PL3737378T3 (pl)
PT (1) PT3737378T (pl)
SI (1) SI3737378T1 (pl)
WO (1) WO2019138162A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220031664A1 (en) * 2020-07-28 2022-02-03 Melt Pharmaceuticals, Inc. Pharmaceutical compositions comprising antiemetics and alpha-2-adrenergic receptor agonists and methods of using the same for anesthesiological applications

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
TWI355936B (en) 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
CN104736144B (zh) 2012-07-27 2019-02-01 艾祖米科技有限公司 外排抑制剂组合物和使用此组合物治疗的方法
CN103845295A (zh) * 2012-12-07 2014-06-11 天津市汉康医药生物技术有限公司 一种注射用帕洛诺司琼制剂及其制备方法
EP3052194B1 (en) * 2013-09-30 2021-06-16 Orion Corporation A veterinary method for inducing emesis

Also Published As

Publication number Publication date
HRP20230471T1 (hr) 2023-07-21
EP3737378A1 (en) 2020-11-18
EP3737378B1 (en) 2023-04-19
PT3737378T (pt) 2023-05-23
WO2019138162A1 (en) 2019-07-18
US11433021B2 (en) 2022-09-06
FI3737378T3 (fi) 2023-06-02
US20200345632A1 (en) 2020-11-05
HUE062180T2 (hu) 2023-09-28
SI3737378T1 (sl) 2023-06-30
DK3737378T3 (da) 2023-05-30
ES2943933T3 (es) 2023-06-16

Similar Documents

Publication Publication Date Title
IL269354A (en) Compounds useful in the treatment or prevention of prmt5-mediated disorder
SG11202104501UA (en) Systems and methods for the treatment of eye conditions
EP3600281A4 (en) COMBINATION THERAPY FOR TREATING OR PREVENTING TUMORS
HUE065585T2 (hu) Integrált sebészeti rendszer a szem szivárványhártya-szaruhártya szögletének kezelésére
EP3334374A4 (en) IMPLANT DAMPING DEVICES FOR TREATING DEMENTIA, AND APPROPRIATE SYSTEMS AND METHODS OF USE THEREOF
HK1250913A1 (zh) 用於治療噁心和嘔吐的氨磺必利和其它止吐藥的組合
ZA202002066B (en) Compositions and methods for the treatment of eye disorders
ZA202101362B (en) Compositions and methods for treating the eye
IL263477A (en) Compositions and methods for the treatment or prevention of oxalate-related disorders
EP3724188C0 (en) PROGRANULIN MODULATORS AND METHODS OF USE THEREOF
IL272121A (en) Preparation and methods for the treatment of myopia
ZA202101342B (en) Compositions and methods for treating the eye
EP3720493C0 (en) COMBINATIONS OF RIPK1 AND IKK INHIBITORS FOR THE PREVENTION OR TREATMENT OF IMMUNE DISEASES
IL282904A (en) Therapeutic microbiota for the treatment and/or prevention of dysbiosis
SG11201809811VA (en) Compositions and methods for treatment of inflammation or infection of the eye
IL272097A (en) Compounds for the prevention and treatment of medical disorders and their uses
IL268591A (en) Rescue treatment after activity of nausea and vomiting
IL287829A (en) Progranulin modulators and methods of using them
EP3728279A4 (en) GLUCOSAMINE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF JOINT DISEASES
ZA202101361B (en) Compositions and methods for treating the eye
ZA202101360B (en) Compositions and methods for treating the eye
ZA202007183B (en) Compositions and methods for treating the eye
PL3737378T3 (pl) Krople do oczu z palonosetronem do leczenia nudności i wymiotów lub zapobiegania im
EP3432875A4 (en) FORMULATION AND METHOD FOR THE PREVENTION AND / OR TREATMENT OF SYMPTOMS OF WOOD HOLINESS
IL275247B1 (en) History of glucosamine for the prevention or treatment of joint disorders